Status:

WITHDRAWN

Teenagers, Drug Addiction, and Reward and Impulse Control

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Conditions:

Adolescents

Conduct Disorder

Eligibility:

All Genders

13-17 years

Brief Summary

Background: \- The risk for becoming addicted to drugs varies from person to person, even among those who use similar drugs in a similar way. Studies suggest that certain personality traits seen in p...

Detailed Description

Background: Even under similar drug use patterns, the risk for drug addiction varies from individual to individual. However, the neurobiological mechanisms underlying this variability are poorly under...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • All participants:
  • Between 13 and 17 years old (inclusive);
  • Must be able to provide informed assent and have a parent/guardian who can provide informed consent;
  • Blood pressure (BP) and heart rate (HR) while sitting at or below the following values after five min rest: Systolic BP (SBP) 140 mm Hg, diastolic BP (DBP) 90 mm Hg, heart rate (HR) 100 bpm;
  • 12-lead standard ECG and three-minute rhythm strip without clinically relevant abnormalities;
  • Estimated IQ (Bullet) 85 determined by the Wechsler Abbreviated Scale of Intelligence (The Psychological Corporation, 1999);
  • Right-handed (based on Edinburgh Handedness Inventory).
  • Eligible to enter the MRI scanner, as determined though self and parent (guardian) report on the MRI screening form (from the screening protocol 06-DA-N415).
  • Group EE:
  • \- History of substance use on 5 or more occasions (not including over-the-counter medications and energy drinks) as assessed through the Substance Use Questionnaire.
  • Group CD-NE:
  • \- History of diagnosis with conduct disorder, assessed from parental or self-report (and verified by study-clinician).
  • Group CD-EE:
  • History of diagnosis with conduct disorder, assessed from parental or self-report (and verified by study-clinician);
  • History of substance use on 5 or more occasions (not including over-the-counter medications and energy drinks) as assessed through the Substance Use Questionnaire.
  • EXCLUSION CRITERIA
  • All participants:
  • Report of a history of significant medical/neurological illness that might interfere with imaging data such as HIV positive status, cerebral vascular accident (CVA), central nervous system (CNS) tumor, traumatic brain injury, multiple sclerosis (MS) or other demyelinating diseases, epilepsy, or movement disorders;
  • History of psychosis or any current DSM-IV axis I disorder (other than simple phobia and conduct disorder);
  • Current use of psychotropic medication that may alter attentional functioning (e.g., Clonidine, antipsychotics, Venlafaxine, stimulants);
  • Current use of substances (not including over-the-counter medications and energy drinks) as assessed by self-report, carbon monoxide (CO) monitoring, alcohol breathalyzer and urine testing;
  • Pregnancy, which will be assessed by history during screening and by urine testing on scan days;
  • Claustrophobia by self and/or parent (guardian) report, or through response to the mock-scanner environment, severe enough to preclude toleration of the scanning environment.
  • Group NE:
  • History of substance use on 5 or more occasions (not including over-the-counter medications and energy drinks) as assessed through the Substance Use Questionnaire;
  • History of diagnosis with conduct disorder, assessed from parental or self-report (and verified by study-clinician).
  • Group EE:
  • \- History of diagnosis with conduct disorder, assessed from parental report (and verified by study-clinician).
  • Group CD-NE:
  • \- History of substance use on 5 or more occasions (not including over-the-counter medications and energy drinks) as assessed through the Substance Use Questionnaire.

Exclusion

    Key Trial Info

    Start Date :

    September 11 2011

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    April 4 2013

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT01443949

    Start Date

    September 11 2011

    End Date

    April 4 2013

    Last Update

    December 12 2019

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.